GlassScriptPhysician profile
Shaun R Senter
NPI 1972659480
$8,090.12
in general payments reported to CMS, 2019-2025
25 companies · $1,071 in 2025
The $1,071 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $145 · 2021: $483 · 2022: $2,373 · 2023: $1,830 · 2024: $2,018 · 2025: $1,071.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,919.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,918.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,002.61 | 2022-2025 | Impella |
| Boston Scientific Corporation | $1,314.55 | 2019-2025 | Resonate El Icd Vr, Latitude Communicator Power Supply, Watchman Access System |
| Inari Medical, INC. | $1,229.91 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $1,030.39 | 2020-2025 | Jeti Peripheral Catheter, Coroflow, Pressurewire |
| Penumbra, INC. | $543.52 | 2022-2024 | Penumbra System, Indigo System |
| Medtronic, INC. | $384.47 | 2022-2025 | Corevalve Evolut R, Selectsecure |
| Philips North America LLC | $235.48 | 2020-2024 | (792) Multi Modality Ivus Other Systems |
| Cvrx, INC. | $223.72 | 2023-2024 | Barostim Neo System |
| Change Healthcare Technologies, LLC | $199.76 | 2022 | |
| Siemens Medical Solutions USA, INC. | $136.00 | 2025 | Naeotom Alpha |
| Stryker Corporation | $119.79 | 2025 | Artix Mt, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $119.14 | 2023-2025 | Repatha, Repatha |
| Edwards Lifesciences Corporation | $116.63 | 2021 | |
| Livanova USA, INC. | $88.85 | 2022 | |
| Pfizer INC. | $74.99 | 2021-2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $55.86 | 2023-2025 | Verquvo |
| Astellas Pharma US INC | $45.68 | 2019 | |
| Bard Peripheral Vascular, INC. | $31.87 | 2021 | |
| Biotronik INC. | $30.33 | 2023-2024 | Orsiro Mission |
| Regeneron Healthcare Solutions, INC. | $27.90 | 2019-2025 | Evkeeza |
| Janssen Pharmaceuticals, INC | $18.64 | 2022 | |
| Avinger INC. | $18.14 | 2023 | Pantheris |
| Amarin Pharma, INC. | $15.84 | 2019 | |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaun Senter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.